Biocompatible 2D Materials via Liquid Phase Exfoliation.

Liquid phase exfoliation bioactive molecules bioapplications biocompatibility two-dimensional materials

Journal

Advanced materials (Deerfield Beach, Fla.)
ISSN: 1521-4095
Titre abrégé: Adv Mater
Pays: Germany
ID NLM: 9885358

Informations de publication

Date de publication:
08 Mar 2024
Historique:
revised: 17 02 2024
received: 21 10 2023
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 8 3 2024
Statut: aheadofprint

Résumé

Two-dimensional materials (2DMs), such as graphene, transition metal dichalcogenides (TMDs) and black phosphorus (BP), have been proposed for different types of bioapplications, owing to their unique physicochemical, electrical, optical and mechanical properties. Liquid phase exfoliation (LPE), as a one of the most effective up-scalable and size-controllable methods, is becoming the standard process to produce high quantity of various 2DM types as it can benefit of the use of green and biocompatible conditions. The resulting exfoliated layered materials have garnered significant attention because of their biocompatibility and their potential use in biomedicine as new multimodal therapeutics, antimicrobials and biosensors. In this review, we focused our attention on the production of LPE-assisted 2DMs in aqueous solutions with or without the aid of surfactants, bioactive or non-natural molecules. We further concluded with our insights into the possibilities of applications of such materials in the biological and biomedical fields. This article is protected by copyright. All rights reserved.

Identifiants

pubmed: 38457626
doi: 10.1002/adma.202310999
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2310999

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Yilin He (Y)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France.

Andrés Felipe Andrade (AF)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France.

Cécilia Ménard-Moyon (C)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France.

Alberto Bianco (A)

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France.

Classifications MeSH